Soleno Therapeutics, Inc. (SLNO) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Soleno Therapeutics, Inc. (SLNO) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.76B, listed on NASDAQ, employing roughly 115 people, carrying a beta of -2.22 to the broader market. Soleno Therapeutics, Inc. Led by Anish Bhatnagar, public since 2014-11-13.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for SLNO as of 2026-07-17; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →